Resources

Main Menu

James P. Mack, EdD

Professor

Ed.D., Teachers College, Columbia University

Office: Edison Science Hall, Room E230

Phone: 732-571-4436

Email: mack@monmouth.edu

Web site: James Mack

Fall 2017 Office Hours:

Monday & Tuesday: 1:15 - 2:15 p.m.

Thursday 10:30 - 11:30 a.m.

Or by appointment

Fall 2017 Courses:

FALL: BY 211 Physiology with Anatomy 1

SPRING: BY 212 Physiology with Anatomy 2

Regularly Taught Courses:

BY 111

BY 112

BY 211

BY 212

About:

I have been researching the efficacy of essential oils and methylglyoxal as antibacterial agents against multidrug-resistant bacteria for fifteen years. Presently, I am focusing my research on the development of topical emollients of essential oils and methylglyoxal in carrier oils to combat multidrug-resistant bacteria to be used in health-care settings.

Research Interests:

1. Study of Antimicrobial Properties of Combination of Essential Oils and Methylglyoxal

2.Development of Topical Emollients Containing the Active Essential Oils and Methylglyoxal to Combat Multidrug-Resistant Bacteria in Health-Care Settings.

Publications:

Scholarly Articles:

 Rosenblum, J. S., Rosenblum, B., Pant, H., Mack, J.P., Schreiber, W. 2017. Cdk5 and Catalase: Interaction of Neuronal Regulation Systems. Nova Science Publishers, Chapter 8, Advances in Medicine and Biology. Vol 121, 173-198.

 Grullon, J., Mack, J.P., Rojtman, A., 2016. Using Essential Oils to Combat the Threat of Multi-Drug Resistant Bacteria, Pseudomonas Aeruginosa. Int Pharm Pharm Sci, 8 (12), 180-183

 Cieslak, E., Mack, J.P., Rojtman, A., 2016. Essential Oils and Methylglyoxal: A Possible Alternative Treatment for Antibiotic Resistant Bacterial Infections. Int J Pharm Pharm Sci, 8 (9),107-110

Qureshi, W.K., Palayekar, V., Dyan, E. Mack, J.P., Rojtman, A., 2015. Combating the Antibiotic Resistance Threat. Int J Pharm Pharm Sci, 7 (2), 68-72.

Sharma, P., Mack, J., Rojtman A., 2013. Ten Highly Effective Essential Oils Inhibit Growth of Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Sensitive Staphylococcus aureus (MSSA). Int J Pharm Pharm Sci, 5 (1): 52-54.